Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A DNA double-strand break induced by high-linear energy transfer irradiation, often abbreviated as "high LET-induced DSB," refers to one of the most severe forms of DNA damage caused when ionizing particles with dense energy deposition—such as heavy ions—traverse cellular nuclei. Unlike low LET radiation (e.g., X-rays), which causes more dispersed and generally less complex lesions that are efficiently repaired via base excision/nucleotide excision pathways, high LET radiation produces clustered and complex breaks along its track through chromatin. These clustered lesions are more difficult for cells to repair accurately due to their complexity and proximity on the genome; they frequently require coordinated action from multiple repair pathways including non-homologous end joining (NHEJ), homologous recombination (HR), microhomology-mediated end joining/TMEJ, among others[1][2]. Failure in efficient repair can result in chromosomal aberrations or cell death through apoptosis—a property exploited therapeutically in certain types of cancer radiotherapy but also posing risks for healthy tissue during accidental exposure or space travel[1][3]. This term does not refer to any specific protein/receptor/enzyme but rather describes an outcome/event at the molecular level following exposure.
Not applicable for direct targeting; however, some drugs (e.g., PARP inhibitors) inhibit repair pathways activated in response to these breaks leading to synthetic lethality in cells with defective homologous recombination. Radioprotective agents may scavenge free radicals generated during irradiation, thereby reducing initial damage.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA double-strand break induced by high-linear energy transfer irradiation.